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Abstract
Severe or chronic wounds related to diseases or serious incidents have received big atten-
tion from not only a scientific standpoint but also a business perspective. Therefore, an 
effective treatment to abridge the long-term hospitalization of severe wound becomes 
indispensable. Glycosaminoglycan (GAG), one of the extracellular matrix molecules 
produced by fibroblasts, participates in cell-cell and cell-matrix interactions, in cell pro-
liferation and migration, and in cytokine and growth factor signaling associated with 
all phases of wound recovery. Natural polysaccharide, for example, calcium alginate, 
which consists of mainly differing ratios of d-mannuronic and l-guluronic acid and rich 
of calcium ions, has been demonstrated to functionalize the glycosaminoglycan activity 
during wound healing. Once the trigger of the underlying wound healing mechanisms 
was understood, it should be possible to find ways to enhance and resolve the wound 
healing process in the patient with conditions and may lead to the potential for treatment 
alternatives in the future clinical field.
Keywords: glycosaminoglycan (GAG), extracellular matrix (ECM) molecules, cytokines, 
natural polysaccharide, wound healing
1. Introduction
Wound injuries are the most common health problem people faced in decades and continu-
ously demand advanced wound management strategies to obtain optimal healing. Wound 
injuries can range from small wounds caused by daily activities to chronic or severe wounds 
caused by diseases or serious incidents. Besides the type of wound being treated, the effective-
ness of wound management also involves a better understanding of different factors such as 
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the healing process and the physical-chemical properties of the available dressings [1]. Mostly 
in small wounds, tissue injuries will heal completely with normal healing phases within 
weeks [2]. On the other hand, severe or chronic wounds are hard to heal within months or a 
year and often reoccur with persistent inflammation [3], which represent major challenges to 
patients medically and financially. Therefore, proper wound dressings that have the ability to 
accelerate the wound healing phases and reduce the healing time simultaneously are required 
to overcome this problem.
Glycosaminoglycans (GAG) are extracellular matrix molecules that have significant roles in the 
control of the all wound healing phases, either an acute wound or severe wound, such as an 
effective mediator of angiogenesis and inflammation [4, 5] and promote the wound recovery by 
leading to rapid granulation, vascularization, and reepithelialization [6]. As a GAG-rich content, 
the use of natural polysaccharide as wound dressing-based material is proposed to enhance the 
healing phases, especially to abridge the long-term healing mechanism in severe wound injury, 
determined by several studies and clinical trials. This chapter will further discuss the detail 
mechanisms and efficacy of natural polysaccharide in accelerating the wound healing process, 
thereby intended to encourage the advanced strategies for future wound management.
2. The involvement of glycosaminoglycan during wound healing
Generally, wound healing has been represented with the complexity and overlapping of 
its phases. These processes integrate a dynamic interaction between cells and extracellular 
matrix (ECM) that trigger tissue or organ regeneration. The significant roles of ECM and its 
components during each stage of the healing process are represented by structural matrix 
provision and function of signal transduction compliance in the dynamic of biological reac-
tions during each stage of the healing process [7, 8–11].
ECM provides structural and functional integrity to connective tissues and organs [12]; yet its 
synthesis and deposition mainly occur in response to growth factors, cytokines, and mechani-
cal signals mediated via cell surface receptors [13]. In the case of wound healing, ECM consists 
of at least four major classes [8]: (1) structural proteins such as the collagens and elastin; (2) 
multidomain adhesive glycoproteins such as fibronectin, vitronectin, and laminin; (3) glycos-
aminoglycan (GAG) such as hyaluronic acid (HA), proteoglycans (PGs) including versican, 
syndecans, glypicans, aggrecan, and perlecan (chondroitin sulfate (CS)/dermatan sulfate 
(DS), and heparin sulfate (HS))—and keratin sulfate (KS), often in large amounts; and (4) 
matricellular proteins such as secreted protein acidic and rich in cysteine (SPARC, also known 
as osteonectin and BM-40), thrombospondins 1 and 2, tenascin C and X, and osteopontin.
GAG is the important constituent of the extracellular matrix found on cell surfaces [14] and 
widely distributed in connective tissues. GAG is composed of characteristic repeating disaccha-
rides, with specific monosaccharides sulfated at each of C
2
, C
3
, C
4
, and C
6
 [15]. These compounds 
are highly anionic polymers, which interact with many cationic species (such as ions and pro-
teins) due to the presence of the carboxylic acid and sulfate functional groups [16]. The negative 
ion charge of GAG molecules carries was considered substantial in many biological processes.
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Among the various molecules secreted by ECM, the GAG has partners that have significant 
roles in the control of the all wound healing phases, either acute wound or severe wound. 
Those molecules participate in cell-cell and cell-matrix interactions, in cell proliferation and 
migration, and in cytokine and growth factor signaling, thus locally modulating their biologic 
activities. In an acute wound, the healing progresses through the normal phases of wound 
healing (hemostasis, inflammation, proliferation, and remodeling) within weeks, while in a 
severe wound, those phases do not progress normally, mostly within months or years, thus 
needing an appropriate supplementary treatment to enhance the healing process. Therefore, 
GAG or GAG-containing material treatment is expected to become a key to turning and accel-
erating not only acute wound but also especially severe or chronic wound healing problems.
2.1. Role of glycosaminoglycan in acute wound healing
2.1.1. Hemostasis phase of wound healing
Hemostasis is the beginning of the wound healing process and may be defined as the interac-
tion between platelets and vessel of vascular injury. The vital mediators of hemostasis are fibrin, 
platelets, and blood vessels. In the first 1 or 2 hours after injury, wound repair starts with the for-
mation of a fibrin matrix through the proteolytic cleavage of fibrinogen by thrombin, and fibrin 
directly binds to platelets to produce a clot [17–21]. The α granules of platelets release numerous 
growth factors, such as PDGF, TGF-α, TGF-β, bFGF, IGF-1, and VEGF [22, 23]. Further, PDGF 
and IGF-1 call up and activate the fibroblasts as well as synthesize GAG and collagen to lead the 
migration and proliferation of the cells into the wound site [24, 25].
The enzymes of the fibrinolytic resist the clot formation. On the other hand, serpins ensure 
that excessive fibrinolytic activity does not occur. The ECM contains a network of scaffold 
proteins that are linked by GAG. GAG, especially HS, plays a key role as anticoagulants that 
have important acts to manage the regulations of many of the serpins [15]. HS represents 
50–90% of the total GAG content [25] and is only in contact with blood when an injury occurs 
[26, 27]. HS has been identified binding with more than 100 proteins involved in hemostasis, 
many growth factors, proteins involved in lipid metabolism, and proteins of the ECM [28]. In 
addition, HS maintains hemostasis as an effective mediator of angiogenesis at the surface of 
endothelial cells [4].
Summarily, the hemostasis phase begins the healing process, generates blood clot formation 
which maintains the structure of vessels, and provides a temporary matrix, secreting cyto-
kines and other growth factors, in order to prepare the wound bed for the next phase of the 
healing process.
2.1.2. Inflammatory phase of wound healing
The inflammatory response is elicited by infection or tissue injury involved in the distribution 
of blood components (plasma and leukocytes) to the damage site [29, 30]. This phase occurs in 
the next 24–48 hours after injury on average accompanied by inflammation symptoms, such 
as redness, body heat, swelling, and pain around the wounded place [31]. Once the bleeding is 
controlled, the key cells of the inflammatory response such as neutrophils, macrophages, and 
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lymphocytes assemble into the wound site, simultaneously release a large number of active 
mediators (cytokines and growth factors), and thus stimulate the inflammatory phase [32–34].
HA, a non-sulfated GAG of the ECM, is involved in a significant process of the inflammatory 
phase. During this phase, HA assembles in the wound bed and regulates early inflammation 
to modulate inflammatory cell and fibroblast cell migration, pro-inflammatory cytokine syn-
thesis, and the phagocytosis of invading microbes [5]. Moreover, HA may bind and improve 
the efficiency of chemokines to neutrophils. Butler et al. revealed that HA appeared able to 
present stimuli to neutrophils [35]. HA on the endothelial surface was increased as well as 
the efficiency of recruitment of neutrophils. In the inflammatory phase, neutrophils collage-
nase and elastase eliminate damaged tissue from the temporary matrix of the wound site, 
while monocytes transform into macrophages and phagocytose fragments of denatured ECM 
debriding the wound site and inactivating any source of microbial infection through the activ-
ity of secreted proteases.
At sites of inflammation, the low-molecular-weight HA fragments (accumulated from deg-
radation of high-molecular-weight HA) can initiate Toll-like receptor 2 and Toll-like recep-
tor 4 induction of pro-inflammatory cytokines IL-6, TNF-α, and IL-1β [36]. Furthermore, the 
growth factors and cytokines released by the inflammatory cells induce the migration and 
proliferation of fibroblast and keratinocyte, which synthesize the levels of HA. All along the 
reepithelialization process, where epithelial cells migrate across the new tissue to form a bar-
rier between the wound and the environment, the level of HA was found significantly ele-
vated [37]. The secretion of cytokines such as TGF-β, PDGF, FGF-2, IL-1, and TNF-α modulate 
collagen deposition by fibroblasts and penetration of new blood vessels into the wound site.
2.1.3. Proliferation phase of wound healing
During the proliferation phase of wound healing, over the next 2 or 3 days and lasts for about 
2 weeks thereafter, the layer of a new matrix by fibroblasts restores the tissue at the wound 
site. The other mesenchymal cells also enter the inflammatory site of the wound in response to 
growth factors that are necessary for the stimulation of cell proliferation [38]. Moreover, fibro-
blasts, endothelial cells, and keratinocytes produce IGF-I, FGF-2, TGF-β, PDGF, and VEGF, 
promoting cell migration and proliferation, matrix synthesis, and angiogenesis.
The fibroblasts synthesize collagen and PGs. Both of them act to form an unstructured con-
nective tissue medium that provides new cells to migrate. A number of PGs were presented 
in the wound site, and their GAG side chains were involved in the stabilization and activation 
of growth factors [15]. Sulfated PGs with CS and DS contribute in collagen polymerization 
[39], and HS PGs on cells can create anchors to the surrounding matrix [40]. The PGs provide 
a matrix for cellular attachment, and some PGs (hyalectans) form ternary complexes with HA 
hydrating the tissue promoting cell survival and migration above the granulation tissue to 
cover the wound site.
2.1.4. Remodeling phase of wound healing
Remodeling is the final phase of wound healing which is achieved over longer periods of up 
to a year after the initial wound injury [41]. This phase is characterized by wound surface 
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contraction [42]. During this phase, new epithelium forms along with the transition of granu-
lation tissue to a mature scar. This process is accompanied by high mechanic strength of the 
formed tissue, reduction of capillary amounts by combining into bigger blood vessels, lower-
ing cell density and metabolic activity of the tissue, and lowering the content of GAG [43, 44]. 
The mechanic strength of the formed tissue equals 25% related to the dermis and equals 80% 
related to the unchanged tissue after many months of reconstruction [43, 45, 46]. Considering 
that GAG activities are able to reduce the inflammatory responses and ECM deposition in the 
early phases of wound healing, a proper wound handling in the beginning of injury with a 
GAG-rich-containing material is expected to heal the wound more closely to normal skin and 
reduce the period of this phase.
2.2. Role of glycosaminoglycan in severe or chronic wound healing
Severe or chronic wounds, hard-to-heal wounds related to diseases or serious incidents, were 
also commonly encountered instead of acute wounds. Mostly, this issue has been associated 
with the aging of the population. Unlike acute wounds, the treatment and management of 
severe wounds represent major challenges to patients medically and financially, resulting in 
a long-term recovery.
Severe wounds are frequently characterized by persistent injury and prolonged inflamma-
tion, high incidence of bacterial biofilms, and excessive proteolysis [3]. Impairment of mac-
rophage function and angiogenic response is also suggested, which are mostly related to 
severe wounds healing process [47, 48]. Due to the prolonged inflammation, an excessive 
recruitment of inflammatory cells to the wound bed will be incurred and produced by the 
large numbers of neutrophils. It is known that neutrophils can eliminate damaged tissue from 
the temporary matrix of the wound site and prevent microbial infection. On the other hand, 
however, the unmanageable neutrophils’ potential to kill pathogens also can lead to excessive 
protease production that initiates significant tissue damage to the host which is harmful to 
wound healing as they cause degradation of the ECM and growth factors [16]. Furthermore, 
the inefficient cell proliferation due to ECM molecule degradation within the wound leads to 
impaired angiogenesis that indicates further wound bed defacement and impaired healing. 
Hence, in order to conquer this issue, the prevention of prolonged inflammation is a goal 
strategy in severe wound therapy.
GAG has been found to bind to neutrophils, macrophages, and lymphocytes which are the 
key cells of the inflammatory response. The effect of excessive protease production caused 
by too many activated neutrophils in the wound site can be inhibited by electrostatic bind-
ing with certain anionic polymers such as GAG or functionalized dextrans [16]. The highly 
anionic nature of GAG that was expected would be ion pairing with the cationic neutrophils 
to interfere the activity of these cationic proteins via charge interactions. Therefore, it may 
be possible that by this mechanism the excessive neutrophil recruitment is reduced and the 
wound can pass from the inflammatory stage to the next stage of healing.
However, after serious tissue injury, the glycanases and proteases can destroy GAG [49]. The 
lack of GAG in severe wounds can be fixed with the addition of GAG-containing material, 
such as a natural polysaccharide, directly into the wound site as a wound dressing. With the 
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rich source of GAG at the wound environment and a better understanding of GAG roles in 
healing processes, it has been possible to formulate therapeutic strategies which are expected 
to accelerate severe wound healing.
3. Natural polysaccharide in wound healing
3.1. The properties of natural polysaccharide
Glycosaminoglycan (GAG) has been shown to perform significant roles in cell signaling and 
development, angiogenesis, anticoagulation, and co-receptors for growth factors, which 
belong to the control of the all wound healing phases, both of acute wound and severe wound. 
GAG is an enormous complex of carbohydrate molecules that interact with several proteins 
involved in physiological and pathological processes [50, 51]. GAG, with a molecular weight 
roughly around 10–100 kDa, is a linear negatively charged polysaccharide. This electrostatic 
characteristic is useful for managing the excessive protease production through ion pairing 
with the cationic neutrophils and interfering the activity of these cationic proteins via charge 
interactions [16]. Once the excessive neutrophil recruitment is reduced as well as the excessive 
protease production, the wound can pass efficiently from the inflammatory stage to the next 
stage of healing, especially for severe wound injury.
Polysaccharides, especially natural polysaccharide, have been extensively used in wound-
dressing development due to their properties such as being biocompatible, nonimmunogenic, 
and antimicrobial [52–54]. They appeared as abundant sources in many different forms of 
plants and production in the body. Based on their availability, a natural polysaccharide with 
different chemical structures and physical properties represents a large source of materials for 
progressive applications in the future, especially in the domain of biomaterials for the medical 
field [55, 56].
Containing a beta-1,3-d-glucan linker, natural polysaccharides contribute to the wound heal-
ing process because of their ability to stimulate immune system activation by activating mac-
rophages that clean up the wound site after injury [57]. The macrophage is one of the major 
inflammatory cells in wounds. It has many substantial functions during wound healing, such 
as host defense, the promotion and resolution of inflammation, the removal of apoptotic cells, 
and the support of cell proliferation and tissue restoration following injury [58]. In several 
studies, natural polysaccharides have been shown to enhance macrophage cytotoxic activity 
against tumor cells and microorganisms and activate phagocytic activity by escalated reactive 
oxygen species (ROS) and nitric oxide (NO) production [59–61]. These abilities are useful for 
enhancing the quality of the wound healing process.
3.2. The effect of natural polysaccharide structure in wound healing: animal studies
Alginate, chitosan, and hyaluronic acid are mainly natural polysaccharides that are consid-
ered as good candidates for the management of wounds in decades. Alginate, as a prominent 
example of a natural polysaccharide with the abundance of GAG, has been utilized to become 
platforms used for fabricating wound dressing materials. Spun as calcium alginate wound 
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dressing, a severe wound injury in swine model treated with this material exhibited a rapid 
reepithelialization and less scar formation, which appeared with a smooth wound, compared 
to commonly used wound dressing [62]. The ability of natural polysaccharide reduces scar 
formation in severe wound injury due to its rich content of GAG which was known to pro-
mote wound healing and leads to rapid granulation, vascularization, and reepithelialization, 
thus yielding a minimum scar formation certainly [6]. As well, once the dressing is attached 
with the wound, an ion exchange reaction occurs between the calcium in the alginate and the 
sodium in the exudate, producing a soluble gel which in turn helps maintain a moist wound 
environment [63]. A moist wound environment will prevent the scab’s formation and facili-
tate the growth and migration of cells to optimize the formation of new tissues.
Regarding immune system activation, the release of pro-inflammatory cytokines, such as 
IL-1β, IL-6, IL-8, IFN-γ, and TNF-α, after wound injury also takes an important part during 
the wound healing process. Various crucial processes at the wound site, such as stimula-
tion of keratinocyte and fibroblast proliferation, synthesis and breakdown of ECM proteins, 
and regulation of immune response, were handled with these cytokines [64]. Their expres-
sions were shown to be intensely upregulated during the inflammatory phase of healing and 
strongly reduced after wound healing was impaired [65].
Natural polysaccharide, by its oligosaccharides (β-glucan, xyloglucan, chitin, pectin, 
d-mannuronic, and l-guluronic), can stimulate human cells to produce cytokines [66, 67]. 
Particularly, the mechanism of β-glucan is mediated by several receptors including dectin-1 
receptor, Toll-like receptors (2, 4, 6), complement receptor 3, scavenger receptor, and lac-
tosylceramide [68]. Once binding to the dectin-1, as the most important receptor, β-glucan 
stimulates the production of many cytokines or activates other immune and nonimmune 
reaction mechanisms [69]. Martins et al. demonstrated that a polysaccharide-rich fraction of 
Agaricus brasiliensis is able to regulate the host response by activating both pro- and anti-
inflammatory mechanisms, thus increasing the production of TNF-α and IL-1β by human 
monocytes through modulation of Toll-like receptor 4 and Toll-like receptor 2 expression [70]. 
In addition, even after TLR blockade, these polysaccharides still activated the monocytes to 
produce considerable levels of IFN-γ, IL-1β, and IL-10. TNF-α and IFN-γ were recognized as 
the important agents of the anti-mycobacterial cytokine cascade, and IL-10 was considered as 
an inhibitory cytokine which is important to the adequate balance between inflammatory and 
immunopathological responses [71]. On the other hand, IL-1β is known as a critical media-
tor of inflammation which is involved in neutrophil mobilization, cellular adhesion to the 
endothelium, and white blood cell infiltration [72, 73]. Zhao et al. determined the wound 
healing effect of an Astragalus membranaceus polysaccharide treatment and its mechanism 
through in vitro and in vivo studies. The results showed that this polysaccharide was able to 
promote human skin fibroblast propagation and accelerate cell cycle progression, as well as 
the reepithelialization, revascularization, and cytokine secretion of TGF-β1, bFGF, and EGF 
which significantly confirmed the accelerated wound closure in mouse wound model [74]. 
TGF-β1 is an important promoter in the fibroblast proliferation and the secretion of ECM and 
inhibits its degradation, while EGF and bFGF are important stimulators in the formation of 
reepithelialization and keratinocyte migration in wound healing [75]. Moreover, the pain and 
the mechanism of pain signals including peripheral and central processing are also related to 
the modulation of TGF-β, which is implicated in the pathogenesis of keloids and hypertrophic 
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scarring [76]. The use of calcium alginate dressing for severe wound injury treatment in the 
animal model demonstrated high levels of TGF-β1, TGF-β2, and TGF-β3, suggesting that it 
might contribute to reduced pain perception [62].
3.3. The application of natural polysaccharide in clinical trials
There are also several clinical trials of natural polysaccharide for wound repair. A natural poly-
saccharide that contains rich GAG has been widely used in the medical field as electrospun regen-
erative materials in the act of matrices that mimic tissues which are being replaced during wound 
healing. HA-based dressings have been used for chronic wound ulcer treatment of various etiolo-
gies, burns, and epithelial surgical wounds. The results revealed that HA significantly upgraded 
the healing process of wounds compared to traditional standards of care [77]. In line with this 
result, chitosan and alginate, fabricated as gelling fiber dressing, have been examined to acceler-
ate the healing of patients with chronic non-healing wounds [78, 79]. This dressing has the ability 
to gel when in contact with wound fluid, less painful to remove, suitable for moderate to high 
exudate, reduced bioburden, and maintain hemostasis. Taken together, all of these benefits nomi-
nate natural polysaccharide as an advisable material in accelerating the wound healing process.
4. Limitation to using natural polysaccharide in wound healing
Generally, natural polysaccharide has demonstrated considerable merit as a treatment for 
chronic wounds for their anti-inflammatory and moist wound environment preservation abili-
ties. Despite, especially for atopy people (the people with genetic tendency to develop allergic 
diseases), a natural polysaccharide may induce the immune system to overreact and cause irri-
tation due to its heterogeneous complex structure. Hence, the control of the molecular weight 
of natural polysaccharide is expected to overcome this limitation. Through the selection of 
desirable molecular weight, we could simplify or remove the excessive part of natural polysac-
charide that may cause the hypersensitivity reaction. Additionally, in the dry wound, these 
properties may also lead to the inefficiency of the wound healing process. They may cause 
dehydration to the dry wound, thus reducing blood flow and the epithelial cells’ migration 
ability around the wound site which interrupts the creation of new tissue. As evidence, reepi-
thelialization of the wound site is more rapid under moist conditions than under dry ones with 
natural polysaccharide wound dressing treatment [80–82]. With controllable molecular weight, 
it is probable that the potential of natural polysaccharide in accelerating the wound healing 
process can be utilized as well into several types of wound injury and patient background.
A natural polysaccharide is the element of human dermal ECM [83–86]. As naturally occurring 
compounds, they have been demonstrated as a great potential for medical, pharmaceutical, 
and biomedical applications, including wound dressings, biomaterials, and tissue regenera-
tion, due to their economical, less toxic, and favorable compatibility profile. However, pos-
sessing a lack of protein structure, natural polysaccharide exhibits a very poor bio-stability 
and difficulty to assemble a “matrix” to bridge the damaged tissue during wound healing 
process, therefore facilitating wound contraction and leading to scar formation [87–89]. To 
address this limitation, natural polysaccharide has been combined with the other natural 
polymers or synthetic polymers to yield the desired bioactive material.
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5. Conclusion and future perspective
Wound dressings have a significant function in the management of wound recovery and have 
been continuously developed upon to improve the quality of the healing process. In this respect, 
a natural polysaccharide, with GAG-rich content, has been shown as a potential candidate to 
enhance the healing process of the wound, especially a severe wound, due to its outstanding 
properties. The detailed mechanism of natural polysaccharide involvement in wound healing 
was presented in this chapter, and it is expected to raise further wound management strate-
gies. For example, recently, 3D bioprinting was expanded in tissue engineering for personal-
ized regenerative medicine; hence, natural polysaccharide can be considerably utilized as the 
bio-ink for the printing of various types of structures as scaffolds as the desired function. The 
combined therapeutic potential of natural polysaccharide and proper development technique 
would be a promising potential not only in the wound management field but also the other 
medical applications.
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